Asset Details
Do you wish to reserve the book?
Effects of hormonal treatment on dermatological outcome in transgender people: a multicentric prospective study (ENIGI)
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Effects of hormonal treatment on dermatological outcome in transgender people: a multicentric prospective study (ENIGI)
Do you wish to request the book?
Effects of hormonal treatment on dermatological outcome in transgender people: a multicentric prospective study (ENIGI)
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Effects of hormonal treatment on dermatological outcome in transgender people: a multicentric prospective study (ENIGI)
2023
Overview
Purpose
The aim of our study was to assess dermatological changes in transgender people after the start of gender-affirming hormonal treatment (GAHT) and to investigate whether various hormonal preparations differently affect dermatological changes in trans AFAB (assigned female at birth) people.
Methods
In a multicenter prospective study, 484 participants (193 assigned male at birth/AMAB and 291 AFAB) were evaluated at baseline (T0), 6 (T1) and 12 months (T2) after the start of GAHT. Hair growth was assessed by the Ferriman–Gallwey (FG) score, acne by the Global Acne Grading Scale (GAGS), and alopecia by the Norwood Hamilton (NH) score.
Results
In AFAB people, a significant increase in FG score and NH grade was observed across time, as well as in GAGS score in a subsample of 71 individuals (
p
< 0.001). Testosterone (T) undecanoate and esters showed a higher increase in hair distribution at T2 vs. T1 as compared to T gel (
p
< 0.01). T esters showed a significantly higher impact in GAGS score modifications at T1 and at T2 vs. T0 compared to T gel (
p
= 0.021 and
p
= 0.003, respectively). In trans AMAB people, a significant decrease of FG score was observed across time (
p
< 0.001), although 51.3% of individuals still reported an FG score higher than eight after 12 months.
Conclusion
T treatment increased hair growth, acne and alopecia prevalence in AFAB people, with T undecanoate and esters influencing hair growth more than T gel. Opposite dermatological changes were observed in AMAB people.
